# Investigation of Docosahexaenoic Acid (DHA) Metabolic Pathway in Human by Using 13C Labeled Molecules

> **NCT02168738** · NA · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 4 (actual)

## Conditions studied

- Healthy Subject

## Interventions

- **DRUG:** 13-C labeled AceDoPC-DHA
- **DRUG:** 13-C labeled TG-DHA
- **DRUG:** 13-C labeled PC-DHA

## Key facts

- **NCT ID:** NCT02168738
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02168738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02168738, "Investigation of Docosahexaenoic Acid (DHA) Metabolic Pathway in Human by Using 13C Labeled Molecules". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT02168738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*